IDTechEx Examines the Opportunities for Wearables in Digital Health
April 19, 2024 | IDTechExEstimated reading time: 3 minutes
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred – medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications as a key focus for their wearable products. IDTechEx’s report, “Digital Health and Artificial Intelligence 2024-2034: Trends, Opportunities, and Outlook”, covers this ongoing trend in the consumer health wearables market and includes analysis of the opportunities and roadmap for biometric monitoring.
Consumer devices battle for medical applications
A direction of travel that has been evident in the wearables industry is the increase in health metrics monitored by smartwatches. A key development in February 2024 was the clearance by the US regulatory body, the Food and Drug Administration (FDA), of the Samsung Galaxy Watch app for the assessment of sleep apnea risk. Sleep apnea is a serious sleep disorder that has significant health implications but is often undiagnosed. The ability to detect silent health conditions via a consumer device has the potential to create improvements in quality of life for a significant population of users. Upcoming consumer electronics, particularly new form factors such as smart rings, promise to bring even more health monitoring capabilities.
Underpinning the sleep apnea detection algorithm are optical sensors capable of detecting the wearer’s blood oxygen levels. While the FDA clearance is significant, the truth is that consumers have been able to check their quality of sleep for signs of sleep apnea, including movement, respiratory rate, and blood oxygen, for several years. The key difference is that with FDA clearance, the devices are no longer categorized as “wellness devices”, which come with major warnings that the data generated are not intended for medical use.
Though there are countless biometrics that can be monitored by smartwatches and other consumer electronics, the reality is that there are only a select few medical conditions that have the potential to drive substantial numbers of new users to these products. When compared to existing diagnostics or monitoring methods, consumer electronics companies will need to prove that comfortable and continuous monitoring provides significant benefit over incumbent technologies, for a large enough market.
The IDTechEx report on digital health discusses opportunities for consumer health wearables, including key value propositions and a roadmap for wearable sensor technology segmented by key biometrics. For additional information on the sensor technologies required for key medical applications in consumer electronics, please refer to the IDTechEx research report Wearable Sensors 2023 – 2033.
Medical device companies eye up the consumer market
On the other end of the spectrum, medtech companies have also been entering the consumer market. Some products, such as the Omron HeartGuide blood pressure monitoring smartwatch launched in 2019, have been specifically designed from the ground up as a consumer health wearable.
However, the key health technology that is making the switch to consumer markets comes in the form of an electronic skin patch. Specifically, the continuous glucose monitor, a majorly disruptive piece of health technology in the Type 1 diabetes market, has been increasingly marketed toward consumers in recent years. These began with niche markets, such as elite athletes competing in endurance sports, but have shifted now to people interested in leveraging data on their metabolism to achieve wellness goals.
Currently, Abbott’s Lingo is available in the UK to help consumers better understand their metabolism and to improve their health. In 2024, rival Dexcom received the first FDA approval to sell a CGM over the counter in the US. Called Stelo, the device will be available in the summer of 2024 and marks a major first step into the digital health for pre- and type 2 diabetes markets. IDTechEx’s report on digital health covers the intersection of the digital health, diabetes, and consumer markets and includes a 10-year forecast for the CGM market from 2024 – 2034.
Suggested Items
Sypris Reports Q1 2024 Results; Revenue Up 10%
05/15/2024 | Sypris Solutions Inc.The Company’s first quarter 2024 consolidated revenue increased 10.1% to $35.6 million compared with the prior-year quarter, representing the 11th quarter of double-digit year-over-year growth during the past 12 quarterly periods.
Peters: Casting Compound Perfectly Protects Electronics from Overheating
05/15/2024 | PetersWith ELPECAST® VU 4545/101, Peters has recently added a casting compound to its product portfolio that is characterised by particularly high thermal conductivity.
Avnet to Exhibit at the 2024 Embedded Vision Summit
05/14/2024 | AvnetAvnet’s exhibit plans for the 2024 Embedded Vision Summit include new development kits supporting AI applications.
Kitron: Completed Share Buyback in Connection with Remuneration to the Board Members
05/14/2024 | KitronKitron ASA has completed share buyback in connection with remuneration to the board members. Reference is made to the stock exchange release by Kitron ASA published on 13. May 2024 regarding initiation of a share buyback program.
Real Time with… IPC APEX EXPO 2024: Digitization and Regular Updates of the iNEMI Industry Roadmap
05/14/2024 | Real Time with...IPC APEX EXPORanjan Chatterjee is a board member at iNEMI. In this conversation with Editor Nolan Johnson, Chatterjee discusses the digitization of, and regular updates to, the industry roadmap. The roadmap is a collaborative effort on technologies and standards which is intended to guide CEOs and CTOs in their long-range planning. Ranjan discusses the board's role in shaping the roadmap and the vision for more frequent updates.